Most impactful areas to clinical real-world evidence as of 2018

Published by
Matej Mikulic,
Feb 4, 2022
This statistic depicts the percentage of executives that selected current and projected areas of most impact to real-world evidence (RWE) in clinical trials, as of 2018. According to the source, 60 percent of executives said that a better understanding of subpopulations and heterogeneity of treatment effects would be most impactful to current real-world evidence.

Percentage of executives that said select areas would be most impactful to current and future real-world evidence (RWE) as of 2018*

CharacteristicCurrentFuture
Better understanding subpopulations and heterogeneity of treatment effects 60% 40%
Understanding burdern of disease 60% 5%
Monitoring patient safety (i.e., pharmacovigilance) 50% 30%
Comparative effectiveness research 35% 20%
Supporting regulatory submission and or label expansion 20% 45%
Accelerating the execution of clinical trials using RWD as a control arm for clinical trials 15% 35%
Optimizing the design of clinical trials 10% 50%
Identifying new drug targets/areas of unmet needs 10% 20%
Design of value-based contracting schemes 5% 40%
Biomarker hypothesis generation/validation 10% 10%
Supporting patient engagement programs 0% 5%
Measuring sales performance, targeting, and marketing metrics 0% 0%
Informing business development and portfolio strategy (therapeutic area assessment) 0% 0%
Showing entries 1 to 13 (14 entries in total)
Created with Highcharts 7.2.2Percentage of respondents40%40%5%5%30%30%20%20%45%45%35%35%50%50%20%20%40%40%10%10%5%5%0%0%0%0%0%0%60%60%60%60%50%50%35%35%20%20%15%15%10%10%10%10%5%5%10%10%0%0%0%0%0%0%0%0%CurrentFutureBetter understanding subpopulations and heterogeneity of treatmenteffectsUnderstanding burdern of diseaseMonitoring patient safety (i.e., pharmacovigilance)Comparative effectiveness researchSupporting regulatory submission and or label expansionAccelerating the execution of clinical trials using RWD as a control armfor clinical trialsOptimizing the design of clinical trialsIdentifying new drug targets/areas of unmet needsDesign of value-based contracting schemesBiomarker hypothesis generation/validationSupporting patient engagement programsMeasuring sales performance, targeting, and marketing metricsInforming business development and portfolio strategy (therapeuticarea assessment)Informing pricing strategies
0%5%10%15%20%25%30%35%40%45%50%55%60%65%70%

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

January 2019

Region

Worldwide

Survey time period

as of 2018

Supplementary notes

* The figures denote current and future application areas ranked among the top three by respondents and expressed as a percentage.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Leading companies trust Statista:
paypal google adobe pg samsung telekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on " Clinical trials "

Other statistics that may interest you Clinical trials

R&D overview

6

Top R&D companies

5

Clinical studies

7

Participation

4

Costs and market

6

Approvals, launches, setbacks

6

COVID-19

4

Further related statistics

10

Discover Statista

Need help with using Statista for your research? Tutorials and first steps

Further Content: You might find this interesting as well

Statistics

Topics

Clinical trialsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.